WebbThe constitutive androstane receptor (CAR) your an nuclear receptor involved mainly in xenobiotic and endobiotic metabolism regulation. AUTOMOBILE is activated directly by its ligands by the ligand binding domain (LBD) press indirectly by restraint of and epidermal plant factor (EGF) indicate. We found that leflunomide (LEF) and it main metabolite … WebbLanthaScreen® Eu Kinase Binding Assay IC50 values (nM) Figure 3 – Validated assays with excellent data quality Figure 11 – Assay is highly resistant to the effects of contaminating kinases Assay of EGFR inhibitors in absence (Purified Kinase) or presence (Purified Kinase + Lysate) of 300
Protein kinase profiling assays: a technology review
WebbLanthaScreen™ TR-FRET PPARγ Competitive Binding Assay Catalog no. PV4894 Shipping: Dry Ice Initial Storage: Varies Protocol part no. PV4894.pps Rev. date: 27 May 2008 For Technical Support on this and other Drug Discovery Products, dial 760-603-7200, option 3, extension 40266 WebbLanthaScreen™ TR-FRET PPAR alpha Competitive Binding Assay Kit, rabbit provides a sensitive and robust method for HTS of ligands for peroxisome proliferator-activated receptor alpha (PPAR alpha). joiscope shoe rack
HTRF technology PerkinElmer
Webb1.16 mg/mL total protein as measured using the Bradford protein assay with BSA as a standard. Assay Concentration(s): 0.5 nM ER beta - LBD (GST) is the final concentration recommended for the LanthaScreen® TR-FRET ER beta Competitive Binding Assay (PV6042). 4 nM ER beta - LBD (GST) is the final concentration recommended for the WebbLanthaScreen® Eu Kinase Binding Assays Kinase Protocols Quicklinks Determine the IC 50 of a control compound Reagents required Quick Reference Protocol Detailed Assay Procedure Related Product Information LanthaScreen Eu Kinase Binding Assay LanthaScreen-TR-FRET-ToolBox Go to... Previous :LanthaScreen® Kinase Activity … WebbIschemic cardiomyopathy leads to inflammation and left ventricular (LV) dysfunction. Animal studies provided evidence for cardioprotective effects of the endocannabinoid system, including cardiomyocyte adaptation, inflammation, and remodeling. Cannabinoid type-2 receptor (CB2) deficiency led to increased apoptosis and infarctions with … joi richardson